Table 1.
Total (n = 56) | Neck node metastasis | |||
---|---|---|---|---|
n | (%) | n | (%) | |
T1 | – | – | – | – |
T2 | 22 | 39.3 | 6 | 27.3 |
T3 | 24 | 42.8 | 13 | 54.2 |
T4 | 10 | 17.9 | 4 | 40 |
Cath-D + (50% and up) | 8 | 14.3 | 6 | 75 |
Cath-D − (Lower than 50%) | 48 | 85.7 | 17 | 35.4 |
E-Cath 25% (negative) | 9 | 16.1 | 5 | 55.6 |
E-Cath 25–75% (reduced) | 32 | 57.1 | 13 | 40.6 |
E-Cath 75% (protected) | 15 | 26.8 | 5 | 33.3 |
Cath-D + E-Cath 25% | 2 | 3.6 | 2 | 100 |
Cath-D + E-Cath 25–75% | 5 | 8.9 | 4 | 80 |
Cath-D + E-Cath 75% | 1 | 1.8 | 0 | 0 |
Cath-D − E-Cath 25% | 7 | 12.5 | 3 | 42.9 |
Cath-D − E-Cath 25–75% | 27 | 48.2 | 9 | 33.3 |
Cath-D − E-Cath 75% | 14 | 25 | 5 | 35.7 |
The metastatic neck lymph nodes rates were found in patients according to Cathepsin D, E-Cadherin expression levels and T stages